A Study on the Proportion and Hospital-Based Prevalence of Non-Alcoholic Fatty Liver Disease in Diagnosed Cases of Polycystic Ovarian Syndrome Seen in a Tertiary Care Centre of Bihar

    Mukta Agarwal, Sudwita Sinha, Swmkwr Basumatary, Divendu Bhushan, Mala Mahto, SG Prem Kumar
    TLDR NAFLD is common in women with PCOS and may signal metabolic syndrome.
    This study aimed to evaluate the prevalence of non-alcoholic fatty liver disease (NAFLD) in women with polycystic ovarian syndrome (PCOS) and involved 86 patients aged 15-35 years. The results showed that 41.87% of the PCOS patients had NAFLD. Overweight and obese patients had significantly higher risks of developing NAFLD, with odds ratios of 27.429 and 36.00, respectively. A waist/hip ratio of ≥0.8 increased the risk by 89 times. Higher testosterone levels and deranged lipid profiles were also associated with increased risk. The study concludes that NAFLD is common in women with PCOS and may indicate metabolic syndrome, suggesting that early screening and intervention could prevent progression to advanced liver disease.
    Discuss this study in the Community →